Combinatorial and sequential delivery of gemcitabine and oseltamivir phosphate from implantable poly(D,L-lactic-co-glycolic acid) cylinders disables human pancreatic cancer cell survival

Combinatorial and sequential delivery of gemcitabine and oseltamivir phosphate from implantable poly(D,L-lactic-co-glycolic acid) cylinders disables human pancreatic cancer cell survival

Stephanie Allison Logan,1 Amanda J Brissenden,1 Myron R Szewczuk,2 Ronald J Neufeld1 1Department of Chemical Engineering, 2Department of Biomedical and Molecular Sciences, Queen’s University, Kingston, ON, Canada Abstract: Combination therapies against multiple targets are currently bein...

Full description

Bibliographic Details
Main Authors: Allison Logan S, Brissenden AJ, Szewczuk MR, Neufeld RJ
Format: Article
Language:English
Published: Dove Medical Press 2017-07-01
Series:Drug Design, Development and Therapy
Subjects:
pancreatic cancer
oseltamivir phosphate
gemcitabine
PLGA
EMT
chemoresistance
Online Access:https://www.dovepress.com/combinatorial-and-sequential-delivery-of-gemcitabine-and-oseltamivir-p-peer-reviewed-article-DDDT

Internet

https://www.dovepress.com/combinatorial-and-sequential-delivery-of-gemcitabine-and-oseltamivir-p-peer-reviewed-article-DDDT

Similar Items